BullFrog AI Holdings (BFRGW) Net Income towards Common Stockholders Growth (1y) (2023 - 2026)
Powered by 
Analysis
BullFrog AI Holdings (BFRGW) Net Income towards Common Stockholders Growth (1y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.04 Bn | 197.05 Bn | 7.24 Bn | 65.85% |
| 2 | Gilead Sciences | 181.32 Bn | 178.14 Bn | 6.22 Bn | -635.24% |
| 3 | Vertex Pharmaceuticals | 132.20 Bn | 124.35 Bn | 2.84 Bn | 6.48% |
| 4 | Regeneron Pharmaceuticals | 82.41 Bn | 74.42 Bn | 3.93 Bn | -6.81% |
| 5 | Argenx Se | 61.58 Bn | 56.39 Bn | 1.37 Bn | 92.37% |
| 6 | Moderna | 54.71 Bn | 49.57 Bn | 52.00 Mn | 5.21% |
| 7 | Alnylam Pharmaceuticals | 34.15 Bn | 30.84 Bn | 992.69 Mn | 327.74% |
| 8 | Biogen | 31.25 Bn | 29.97 Bn | 1.96 Bn | -84.64% |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn | - |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 | 5.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.33% |
| Dec 31, 2025 | 15.08% |
| Sep 30, 2025 | 12.01% |
| Jun 30, 2025 | 10.11% |
| Mar 31, 2025 | -5.05% |
| Dec 31, 2024 | -34.39% |
| Sep 30, 2024 | -40.74% |
| Jun 30, 2024 | -8.87% |
| Mar 31, 2024 | -44.89% |
| Dec 31, 2023 | -86.47% |
| Sep 30, 2023 | -63.85% |
| Jun 30, 2023 | -90.78% |
| Mar 31, 2023 | -133.89% |